Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation

British Journal of Haematology

Volumn 174, Issue 2, 2016, Pages 235-248

  Fenske, Timothy S ^a   Ahn, Kwang W ^b   Graff, Tara M ^c   DiGilio, Alyssa ^b   Bashir, Qaiser ^d   Kamble, Rammurti T ^e   Ayala, Ernesto ^f   Bacher, Ulrike ^g,h   Brammer, Jonathan E ^d   Cairo, Mitchell ⁱ   Chen, Andy ^j   Chen, Yi Bin ^k   Chhabra, Saurabh ^l   D'Souza, Anita ^b   Farooq, Umar ^m   Freytes, Cesar ⁿ   Ganguly, Siddhartha ^o   Hertzberg, Mark ^p   Inwards, David ^q   Jaglowski, Samantha ^r   Kharfan Dabaja, Mohamed A ^f   Lazarus, Hillard M ^s   Nathan, Sunita ^t   Pawarode, Attaphol ^u   Perales, Miguel Angel ^v   Reddy, Nishitha ^w   Seo, Sachiko ^x   Sureda, Anna ^y,z   Smith, Sonali M ^aa   Hamadani, Mehdi ^a,b   more..

^a FROEDTERT MEMORIAL LUTHERAN HOSPITAL   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c Medical Oncology and Hematology Associates   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e CENTER FOR CELL AND GENE THERAPY   (United States)

^f H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^g UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^h UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

ⁱ NEW YORK MEDICAL COLLEGE   (United States)

^j OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^k MASSACHUSETTS GENERAL HOSPITAL   (United States)

^l MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^m UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

ⁿ UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^o UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^p PRINCE OF WALES HOSPITAL   (Australia)

^q MAYO CLINIC   (United States)

^r THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^s UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^t RUSH UNIVERSITY MEDICAL CENTER   (United States)

^u UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^v MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^w VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^x USA   (United States)

^y HOSPITAL DURAN I REYNALS   (Spain)

^z European Group for Blood and Marrow Transplantation Lymphoma Working Party   (Spain)

^aa UNIVERSITY OF CHICAGO   (United States)

more..

Author keywords

Allogeneic transplantation; DLBCL; Prior autologous transplan; Prognostic score

Indexed keywords

ADULT; AGED; ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION; CANCER PROGNOSIS; CANCER RISK; CANCER SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; INTERMEDIATE RISK PATIENT; LARGE CELL LYMPHOMA; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RISK; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; TREATMENT RESPONSE; VERY HIGH RISK PATIENT;

EID: 84978080661     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.14046     Document Type: Article

References (26)

1. Bachanova, V., Burns, L.J., Ahn, K.W., Laport, G.G., Akpek, G., Kharfan-Dabaja, M.A., Nishihori, T., Agura, E., Armand, P., Jaglowski, S.M., Cairo, M.S., Cashen, A.F., Cohen, J.B., D'Souza, A., Freytes, C.O., Gale, R.P., Ganguly, S., Ghosh, N., Holmberg, L.A., Inwards, D.J., Kanate, A.S., Lazarus, H.M., Malone, A.K., Munker, R., Mussetti, A., Norkin, M., Prestidge, T.D., Rowe, J.M., Satwani, P., Siddiqi, T., Stiff, P.J., William, B.M., Wirk, B., Maloney, D.G., Smith, S.M., Sureda, A.M., Carreras, J. & Hamadani, M. & Center for International Blood and Marrow Transplant Research Lymphoma Working Committee. (2015) Impact of pretransplantation (18)F-fluorodeoxy glucose-positron emission tomography status on outcomes after allogeneic hematopoietic cell transplantation for non-hodgkin lymphoma. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 21, 1605–1611.
2. Bacher, U., Klyuchnikov, E., Le-Rademacher, J., Carreras, J., Armand, P., Bishop, M.R., Bredeson, C.N., Cairo, M.S., Fenske, T.S., Freytes, C.O., Gale, R.P., Gibson, J., Isola, L.M., Inwards, D.J., Laport, G.G., Lazarus, H.M., Maziarz, R.T., Wiernik, P.H., Schouten, H.C., Slavin, S., Smith, S.M., Vose, J.M., Waller, E.K. & Hari, P.N. & Lymphoma Working Committee of the CIBMTR. (2012) Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: Myeloablative or reduced intensity? Blood, 120, 4256–4262.
3. Bacigalupo, A., Ballen, K., Rizzo, D., Giralt, S., Lazarus, H., Ho, V., Apperley, J., Slavin, S., Pasquini, M., Sandmaier, B.M., Barrett, J., Blaise, D., Lowski, R. & Horowitz, M. (2009) Defining the intensity of conditioning regimens: working definitions. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 15, 1628–1633.
4. Bishop, M.R., Dean, R.M., Steinberg, S.M., Odom, J., Pavletic, S.Z., Chow, C., Pittaluga, S., Sportes, C., Hardy, N.M., Gea-Banacloche, J., Kolstad, A., Gress, R.E. & Fowler, D.H. (2008) Clinical evidence of a graft-versus-lymphoma effect against relapsed diffuse large B-cell lymphoma after allogeneic hematopoietic stem-cell transplantation. Annals of Oncology: Official Journal of the European Society for Medical Oncology/ESMO, 19, 1935–1940.
5. Fenske, T.S., Hari, P.N., Carreras, J., Zhang, M.J., Kamble, R.T., Bolwell, B.J., Cairo, M.S., Champlin, R.E., Chen, Y.B., Freytes, C.O., Gale, R.P., Hale, G.A., Ilhan, O., Khoury, H.J., Lister, J., Maharaj, D., Marks, D.I., Munker, R., Pecora, A.L., Rowlings, P.A., Shea, T.C., Stiff, P., Wiernik, P.H., Winter, J.N., Rizzo, J.D., van Besien, K., Lazarus, H.M. & Vose, J.M. (2009) Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 15, 1455–1464.
6. Gisselbrecht, C., Glass, B., Mounier, N., Singh Gill, D., Linch, D.C., Trneny, M., Bosly, A., Ketterer, N., Shpilberg, O., Hagberg, H., Ma, D., Briere, J., Moskowitz, C.H. & Schmitz, N. (2010) Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 28, 4184–4190.
7. Gu, K., Weisenburger, D.D., Fu, K., Chan, W.C., Greiner, T.C., Aoun, P., Smith, L.M., Bast, M., Liu, Z., Bociek, R.G., Bierman, P.J., Armitage, J.O. & Vose, J.M. (2012) Cell of origin fails to predict survival in patients with diffuse large B-cell lymphoma treated with autologous hematopoietic stem cell transplantation. Hematological Oncology, 30, 143–149.
8. Hamadani, M., Saber, W., Ahn, K.W., Carreras, J., Cairo, M.S., Fenske, T.S., Gale, R.P., Gibson, J., Hale, G.A., Hari, P.N., Hsu, J.W., Inwards, D.J., Kamble, R.T., Klein, A., Maharaj, D., Marks, D.I., Rizzieri, D.A., Savani, B.N., Schouten, H.C., Waller, E.K., Wirk, B., Laport, G.G., Montoto, S., Maloney, D.G. & Lazarus, H.M. (2013) Impact of pretransplantation conditioning regimens on outcomes of allogeneic transplantation for chemotherapy-unresponsive diffuse large B cell lymphoma and grade III follicular lymphoma. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 19, 746–753.
9. Hamadani, M., Hari, P.N., Zhang, Y., Carreras, J., Akpek, G., Aljurf, M.D., Ayala, E., Bachanova, V., Chen, A.I., Chen, Y.B., Costa, L.J., Fenske, T.S., Freytes, C.O., Ganguly, S., Hertzberg, M.S., Holmberg, L.A., Inwards, D.J., Kamble, R.T., Kanfer, E.J., Lazarus, H.M., Marks, D.I., Nishihori, T., Olsson, R., Reddy, N.M., Rizzieri, D.A., Savani, B.N., Solh, M., Vose, J.M., Wirk, B., Maloney, D.G., Smith, S.M., Montoto, S., Saber, W., Alpdogan, O., Cashen, A., Dandoy, C., Finke, R., Gale, R., Gibson, J., Hsu, J.W., Janakiraman, N., Laughlin, M.J., Lill, M., Cairo, M.S., Munker, R., Rowlings, P.A., Schouten, H.C., Shea, T.C., Stiff, P.J. & Waller, E.K. (2014) Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 20, 1729–1736.
10. van Kampen, R.J., Canals, C., Schouten, H.C., Nagler, A., Thomson, K.J., Vernant, J.P., Buzyn, A., Boogaerts, M.A., Luan, J.J., Maury, S., Milpied, N.J., Jouet, J.P., Ossenkoppele, G.J. & Sureda, A. (2011) Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large B-cell non-hodgkin's lymphoma relapsing after an autologous stem-cell transplantation: an analysis of the european group for blood and marrow transplantation registry. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 29, 1342–1348.
11. Kim, J.W., Kim, S.W., Tada, K., Fukuda, T., Lee, J.H., Lee, J.J., Kwon, J.H., Bang, S.M., Kim, I., Yoon, S.S., Lee, J.S. & Park, S. (2014) Allogeneic stem cell transplantation in patients with de novo diffuse large B-cell lymphoma who experienced relapse or progression after autologous stem cell transplantation: a korea-japan collaborative study. Annals of Hematology, 93, 1345–1351.
12. Klyuchnikov, E., Bacher, U., Kroll, T., Shea, T.C., Lazarus, H.M., Bredeson, C. & Fenske, T.S. (2014) Allogeneic hematopoietic cell transplantation for diffuse large B cell lymphoma: who, when and how? Bone Marrow Transplantation, 49, 1–7.
13. Moskowitz, C.H., Zelenetz, A.D., Kewalramani, T., Hamlin, P., Lessac-Chenen, S., Houldsworth, J., Olshen, A., Chaganti, R., Nimer, S. & Teruya-Feldstein, J. (2005) Cell of origin, germinal center versus nongerminal center, determined by immunohistochemistry on tissue microarray, does not correlate with outcome in patients with relapsed and refractory DLBCL. Blood, 106, 3383–3385.
14. Mounier, N., Canals, C., Gisselbrecht, C., Cornelissen, J., Foa, R., Conde, E., Maertens, J., Attal, M., Rambaldi, A., Crawley, C., Luan, J.J., Brune, M., Wittnebel, S., Cook, G., vanImhoff, G.W., Pfreundschuh, M. & Sureda, A. & Lymphoma Working Party of European Blood and Marrow Transplantation Registry (EBMT). (2012) High-dose therapy and autologous stem cell transplantation in first relapse for diffuse large B cell lymphoma in the rituximab era: an analysis based on data from the european blood and marrow transplantation registry. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 18, 788–793.
15. Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van der Lelie, H., Bron, D., Sonneveld, P., Gisselbrecht, C., Cahn, J.Y. & Harousseau, J.L. (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-hodgkin's lymphoma. The New England Journal of Medicine, 333, 1540–1545.
16. Przepiorka, D., Weisdorf, D., Martin, P., Klingemann, H.G., Beatty, P., Hows, J. & Thomas, E.D. (1995) 1994 consensus conference on acute GVHD grading. Bone Marrow Transplantation, 15, 825–828.
17. Rezvani, A.R., Norasetthada, L., Gooley, T., Sorror, M., Bouvier, M.E., Sahebi, F., Agura, E., Chauncey, T., Maziarz, R.T., Maris, M., Shizuru, J., Bruno, B., Bredeson, C., Lange, T., Yeager, A., Sandmaier, B.M., Storb, R.F. & Maloney, D.G. (2008) Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experience. British Journal of Haematology, 143, 395–403.
18. Rigacci, L., Puccini, B., Dodero, A., Iacopino, P., Castagna, L., Bramanti, S., Ciceri, F., Fanin, R., Rambaldi, A., Falda, M., Milone, G., Guidi, S., Martelli, M.F., Mazza, P., Oneto, R. & Bosi, A. & Gruppo Italiano Trapianto di Midollo Osseo (GITMO). (2012) Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study. Annals of Hematology, 91, 931–939.
19. Shulman, H.M., Sullivan, K.M., Weiden, P.L., McDonald, G.B., Striker, G.E., Sale, G.E., Hackman, R., Tsoi, M.S., Storb, R. & Thomas, E.D. (1980) Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 seattle patients. The American Journal of Medicine, 69, 204–217.
20. Sirvent, A., Dhedin, N., Michallet, M., Mounier, N., Faucher, C., Yakoub-Agha, I., Mohty, M., Robin, M., Tabrizi, R., Clement, L., Bilger, K., Larosa, F., Contentin, N., Huyn, A., Francois, S., Bulabois, C.E., Ceballos, P., Bourrhis, J.H., Buzyn, A., Cornillon, J., Guillerm, G., de Revel, T., Bay, J.O., Guilhot, F. & Milpied, N. (2010) Low nonrelapse mortality and prolonged long-term survival after reduced-intensity allogeneic stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma: report of the societe francaise de greffe de moelle et de therapie cellulaire. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 16, 78–85.
21. Thieblemont, C., Briere, J., Mounier, N., Voelker, H.U., Cuccuini, W., Hirchaud, E., Rosenwald, A., Jack, A., Sundstrom, C., Cogliatti, S., Trougouboff, P., Boudova, L., Ysebaert, L., Soulier, J., Chevalier, C., Bron, D., Schmitz, N., Gaulard, P., Houlgatte, R. & Gisselbrecht, C. (2011) The germinal center/activated B-cell subclassification has a prognostic impact for response to salvage therapy in relapsed/refractory diffuse large B-cell lymphoma: a bio-CORAL study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 29, 4079–4087.
22. Thomson, K.J., Morris, E.C., Bloor, A., Cook, G., Milligan, D., Parker, A., Clark, F., Yung, L., Linch, D.C., Chakraverty, R., Peggs, K.S. & Mackinnon, S. (2009) Favorable long-term survival after reduced-intensity allogeneic transplantation for multiple-relapse aggressive non-hodgkin's lymphoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 27, 426–432.
23. Urbano-Ispizua, A., Pavletic, S.Z., Flowers, M.E., Klein, J.P., Zhang, M.J., Carreras, J., Montoto, S., Perales, M.A., Aljurf, M.D., Akpek, G., Bredeson, C.N., Costa, L.J., Dandoy, C., Freytes, C.O., Fung, H.C., Gale, R.P., Gibson, J., Hamadani, M., Hayashi, R.J., Inamoto, Y., Inwards, D.J., Lazarus, H.M., Maloney, D.G., Martino, R., Munker, R., Nishihori, T., Olsson, R.F., Rizzieri, D.A., Reshef, R., Saad, A., Savani, B.N., Schouten, H.C., Smith, S.M., Socie, G., Wirk, B., Yu, L.C. & Saber, W. (2015) The impact of graft-versus-host disease on the relapse rate in patients with lymphoma depends on the histological subtype and the intensity of the conditioning regimen. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 21, 1746–1753.
24. Weisdorf, D., Spellman, S., Haagenson, M., Horowitz, M., Lee, S., Anasetti, C., Setterholm, M., Drexler, R., Maiers, M., King, R., Confer, D. & Klein, J. (2008) Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 14, 748–758.
25. Zhang, X. & Zhang, M.J. (2011) SAS macros for estimation of direct adjusted cumulative incidence curves under proportional subdistribution hazards models. Computer Methods and Programs in Biomedicine, 101, 87–93.
26. Zhang, X., Loberiza, F.R., Klein, J.P. & Zhang, M.J. (2007) A SAS macro for estimation of direct adjusted survival curves based on a stratified cox regression model. Computer Methods and Programs in Biomedicine, 88, 95–101.